207940
vs
REGN
207940
REGN
Over the past 12 months, Samsung Biologics Co Ltd has significantly outperformed REGN, delivering a return of +71% compared to the REGN's +18% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
207940
REGN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Samsung Biologics Co Ltd
KRX:207940
|
1 710 000
KRW
|
|||||
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
790.5
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
207940, REGN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Samsung Biologics Co Ltd
Revenue
|
|||||||||||
|
Regeneron Pharmaceuticals Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
207940, REGN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Samsung Biologics Co Ltd
KRX:207940
|
|||||||||
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Samsung Biologics Co Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Samsung Biologics Co Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Samsung Biologics Co Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Samsung Biologics Co Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Samsung Biologics Co Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Samsung Biologics Co Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Samsung Biologics Co Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Samsung Biologics Co Ltd | ||||
|
Regeneron Pharmaceuticals Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
207940, REGN
Performance Gap
207940, REGN
Performance By Year
207940, REGN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
|
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
|
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|